Vanda Pharmaceuticals, Inc. (VNDA)
7.44
+0.05
(+0.68%)
USD |
NASDAQ |
May 06, 16:00
7.22
-0.22
(-2.96%)
Pre-Market: 08:20
Vanda Pharmaceuticals Free Cash Flow : -110.44M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 10.37B |
| AnaptysBio, Inc. | 19.61M |
| Gossamer Bio, Inc. | -171.34M |
| BridgeBio Pharma, Inc. | -455.50M |
| Arcellx, Inc. | -212.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -29.42M |
| Cash from Investing (Quarterly) | 44.87M |
| Cash from Financing (Quarterly) | -0.64M |
| Free Cash Flow Per Share (Quarterly) | -0.4995 |
| Free Cash Flow to Equity (Quarterly) | -31.23M |
| Free Cash Flow to Firm (Quarterly) | -29.52M |
| Free Cash Flow Yield | -25.19% |